COMPARATIVE ASSESSMENT OF GEFITINIB AND ERLOTINIB THERAPY IN SUBJECTS WITH NON-SMALL CELL LUNG CARCINOMA. Int. Res. J. Pharm. [Internet]. 2023 Sep. 2 [cited 2026 May 30];14(9):1-5. Available from: https://irjponline.org/index.php/irjp/article/view/64